TrialThe Journal of clinical endocrinology and metabolism2025

Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.

Anne L Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.